“Higher Risk of Malignancy in Male Patients with Sweet Syndrome and Certain Clinical Features: A Retrospective Study Recommending Minimum 6-Month Follow-Up”

https://pubmed.ncbi.nlm.nih.gov/38112209

In this retrospective study of 93 patients with Sweet syndrome, a higher risk of malignancy was found in patients who were male, had fever, increased erythrocyte sedimentation rate, anemia, and thrombocytopenia, and a minimum follow-up of 6 months is recommended.